Literature DB >> 3605738

Assay methods for fentanyl in serum: gas-liquid chromatography versus radioimmunoassay.

R J Woestenborghs, D R Stanski, J C Scott, J J Heykants.   

Abstract

In this study, two independent laboratories assessed the validity of the fentanyl radioimmunoassay (RIA) by measuring a series of spiked control serum samples and 429 serum samples from 20 patients receiving fentanyl for their anesthesia. Additionally, a gas-liquid chromatographic (GLC) method specific for the parent drug was also applied to the same serum samples. The RIA measurement of fentanyl by the two laboratories resulted in comparable values for both control samples and samples from patients in a range of 0.5-50 ng/ml. The GLC method agreed with both RIA measurements in the spiked control and patient samples. The authors' results demonstrate the validity of the RIA as a measurement technique for fentanyl in human serum samples.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605738     DOI: 10.1097/00000542-198707000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  Development of a GC-MS assay for the determination of fentanyl pharmacokinetics in rabbit plasma after sublingual spray delivery.

Authors:  Ahmad H Malkawi; Abeer M Al-Ghananeem; Peter A Crooks
Journal:  AAPS J       Date:  2008-05-06       Impact factor: 4.009

2.  Correction to: Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

3.  Plasma sufentanil concentration after intranasal administration to paediatric outpatients.

Authors:  G Haynes; N H Brahen; H F Hill
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

Review 4.  Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.

Authors:  Victoria C Ziesenitz; Janelle D Vaughns; Gilbert Koch; Gerd Mikus; Johannes N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-02       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.